9 results
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
across all patients, regardless of body mass index (BMI), race, or ethnicity. Table of Contents 6
Foresight® Carrier Screen: a prenatal test
ARS
2022 FY
MYGN
Myriad Genetics, Inc.
12 Apr 23
Annual report to shareholders
4:10pm
for equity in care across all patients, regardless of body mass index (BMI), race, or ethnicity. Table of Contents 6
Foresight® Carrier Screen: a prenatal
10-KT
hknm3qmrdpnt5dttsu1
16 Mar 21
Annual report (with FYE transition)
2:24pm
8-K
EX-99.1
pcf44w9efa
9 Nov 20
Test Volumes Reach 90% of Pre-COVID-19 Level at End of Quarter
8:02am
8-K
EX-99.1
3od76
13 Aug 20
Myriad Genetics Reports Fiscal Fourth-Quarter 2020 Financial Results
4:15pm
- Prev
- 1
- Next